Article
Using anti-Müllerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional study
18 Nov 2024
Abstract excerpt
Background: Premature ovarian insufficiency/failure (POI/POF) is a significant issue for women of reproductive age. Anti-Müllerian hormone (AMH) is a potential biomarker of ovarian reserve, but its clinical value in diagnosing and predicting POI/POF remains unclear. This study aimed to analyze the correlation between AMH and basal follicle-stimulating hormone (FSH) levels in women aged 18 to 40 and evaluate AMH's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
